147 related articles for article (PubMed ID: 36127550)
1. Serum metabolite differences detected by HILIC UHPLC-Q-TOF MS in systemic sclerosis.
Sun C; Zhu H; Wang Y; Han Y; Zhang D; Cao X; Alip M; Nie M; Xu X; Lv L; Feng X; Sun L; Wang D
Clin Rheumatol; 2023 Jan; 42(1):125-134. PubMed ID: 36127550
[TBL] [Abstract][Full Text] [Related]
2. Serum metabolomic profiling reveals potential biomarkers in systemic sclerosis.
Guo M; Liu D; Jiang Y; Chen W; Zhao L; Bao D; Li Y; Distler JHW; Zhu H
Metabolism; 2023 Jul; 144():155587. PubMed ID: 37156409
[TBL] [Abstract][Full Text] [Related]
3. Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis.
Corrado A; Colia R; Mele A; Di Bello V; Trotta A; Neve A; Cantatore FP
PLoS One; 2015; 10(9):e0137912. PubMed ID: 26375284
[TBL] [Abstract][Full Text] [Related]
4. Serum microRNAs in Systemic Sclerosis, Associations with Digital Vasculopathy and Lung Involvement.
Wajda A; Walczyk M; Dudek E; Stypińska B; Lewandowska A; Romanowska-Próchnicka K; Chojnowski M; Olesińska M; Paradowska-Gorycka A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142646
[No Abstract] [Full Text] [Related]
5. Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis.
Rimar D; Rosner I; Nov Y; Slobodin G; Rozenbaum M; Halasz K; Haj T; Jiries N; Kaly L; Boulman N; Daood R; Vadasz Z
Arthritis Rheumatol; 2014 Mar; 66(3):726-30. PubMed ID: 24574233
[TBL] [Abstract][Full Text] [Related]
6. Association of serum Ly6/PLAUR domain-containing protein 1 levels with skin sclerosis in systemic sclerosis.
Sugimori A; Omori I; Iwasawa O; Saito H; Nakajima H; Matsuno A; Sato S; Sumida H
Sci Rep; 2024 Mar; 14(1):5572. PubMed ID: 38448661
[TBL] [Abstract][Full Text] [Related]
7. Metabolic fingerprinting of systemic sclerosis: a systematic review.
Morales-González V; Galeano-Sánchez D; Covaleda-Vargas JE; Rodriguez Y; Monsalve DM; Pardo-Rodriguez D; Cala MP; Acosta-Ampudia Y; Ramírez-Santana C
Front Mol Biosci; 2023; 10():1215039. PubMed ID: 37614441
[No Abstract] [Full Text] [Related]
8. Serum YKL-40 and IL-6 levels correlate with ultrasound findings of articular and periarticular involvement in patients with systemic sclerosis.
Karalilova R; Kazakova M; Sapundzhieva T; Dichev V; Batalov Z; Sarafian V; Batalov A
Rheumatol Int; 2019 Nov; 39(11):1841-1848. PubMed ID: 31375891
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic profile of systemic sclerosis patients.
Murgia F; Svegliati S; Poddighe S; Lussu M; Manzin A; Spadoni T; Fischetti C; Gabrielli A; Atzori L
Sci Rep; 2018 May; 8(1):7626. PubMed ID: 29769578
[TBL] [Abstract][Full Text] [Related]
10. Urinary and plasma metabolite differences detected by HPLC-ESI-QTOF-MS in systemic sclerosis patients.
Fernández-Ochoa Á; Quirantes-Piné R; Borrás-Linares I; Gemperline D; ; Alarcón Riquelme ME; Beretta L; Segura-Carretero A
J Pharm Biomed Anal; 2019 Jan; 162():82-90. PubMed ID: 30227356
[TBL] [Abstract][Full Text] [Related]
11. Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis.
Moinzadeh P; Aberer E; Ahmadi-Simab K; Blank N; Distler JH; Fierlbeck G; Genth E; Guenther C; Hein R; Henes J; Herich L; Herrgott I; Koetter I; Kreuter A; Krieg T; Kuhr K; Lorenz HM; Meier F; Melchers I; Mensing H; Mueller-Ladner U; Pfeiffer C; Riemekasten G; Sárdy M; Schmalzing M; Sunderkoetter C; Susok L; Tarner IH; Vaith P; Worm M; Wozel G; Zeidler G; Hunzelmann N;
Ann Rheum Dis; 2015 Apr; 74(4):730-7. PubMed ID: 24389298
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of serum retinol binding protein-4 levels in patients with systemic sclerosis.
Toyama T; Asano Y; Takahashi T; Aozasa N; Akamata K; Noda S; Taniguchi T; Ichimura Y; Sumida H; Tamaki Z; Masui Y; Tada Y; Sugaya M; Sato S; Kadono T
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):337-44. PubMed ID: 22211766
[TBL] [Abstract][Full Text] [Related]
13. [Altered serum cytokine expression profile in systemic sclerosis and its regulatory mechanisms].
Zhu HL; DU Q; Chen WL; Zuo XX; Li QZ; Liu SJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):716-722. PubMed ID: 31420628
[TBL] [Abstract][Full Text] [Related]
14. A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis.
Noda S; Asano Y; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
PLoS One; 2012; 7(2):e32272. PubMed ID: 22384200
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype.
van Bon L; Cossu M; Loof A; Gohar F; Wittkowski H; Vonk M; Roth J; van den Berg W; van Heerde W; Broen JC; Radstake TR
Ann Rheum Dis; 2014 Aug; 73(8):1585-9. PubMed ID: 24718960
[TBL] [Abstract][Full Text] [Related]
16.
Zmorzyński S; Wojcierowska-Litwin M; Kowal M; Michalska-Jakubus M; Styk W; Filip AA; Walecka I; Krasowska D
Biomed Res Int; 2020; 2020():8465971. PubMed ID: 32185220
[TBL] [Abstract][Full Text] [Related]
17. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis.
Meyer OC; Fertig N; Lucas M; Somogyi N; Medsger TA
J Rheumatol; 2007 Jan; 34(1):104-9. PubMed ID: 17117486
[TBL] [Abstract][Full Text] [Related]
18. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
[TBL] [Abstract][Full Text] [Related]
19. Spleen elastography in patients with Systemic sclerosis.
Karalilova R; Doykova K; Batalov Z; Doykov D; Batalov A
Rheumatol Int; 2021 Mar; 41(3):633-641. PubMed ID: 33495915
[TBL] [Abstract][Full Text] [Related]
20. Serum vasohibin-1 levels: A potential marker of dermal and pulmonary fibrosis in systemic sclerosis.
Fukui Y; Nakamura K; Hirabayashi M; Miyagawa T; Toyama S; Omatsu J; Awaji K; Ikawa T; Norimatsu Y; Yoshizaki A; Sato S; Asano Y
Exp Dermatol; 2021 Jul; 30(7):951-958. PubMed ID: 33682189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
